In fact, this has been evidenced by numerous studies reporting an increased incidence of breast, ovarian, pancreatic, or prostate cancer tightly associated with the heterozygosity of several FA genes (FANCD1, FANCJ, FANCN, FANCO or/and FANCS) [22, 46-57]. Here, PALB2 is linked to prostate carcinoma.